IPR -- THE BACKBONE OF THE BIOTECH INDUSTRY

In India, the pharma industry is one of the first to reap the benefits of biotechnology. Human health biotechnology products account for about 60 percent of the domestic market, while bio-drugs, vaccines and diagnostics have significant market shares as well. Consequently, Indian pharma is beginning to benefit from enhanced IP protection of their products.

Express Pharma (http://www.expresspharmapulse.com/20060315/management03.shtml)